New York Life Investment Management LLC Purchases 769 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

New York Life Investment Management LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 141,339 shares of the healthcare conglomerate’s stock after acquiring an additional 769 shares during the quarter. UnitedHealth Group accounts for 0.7% of New York Life Investment Management LLC’s holdings, making the stock its 22nd largest holding. New York Life Investment Management LLC’s holdings in UnitedHealth Group were worth $71,978,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the business. Bell Investment Advisors Inc boosted its stake in shares of UnitedHealth Group by 4.8% in the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 24 shares in the last quarter. Harbor Investment Advisory LLC grew its position in UnitedHealth Group by 3.2% during the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock worth $17,783,000 after acquiring an additional 1,129 shares during the last quarter. Austin Private Wealth LLC boosted its stake in shares of UnitedHealth Group by 9.8% during the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after purchasing an additional 111 shares in the last quarter. Vanguard Personalized Indexing Management LLC raised its holdings in UnitedHealth Group by 7.9% in the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 75,602 shares of the healthcare conglomerate’s stock valued at $39,802,000 after buying an additional 5,537 shares during the last quarter. Finally, Capital Insight Partners LLC grew its holdings in UnitedHealth Group by 3.8% during the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock worth $4,475,000 after acquiring an additional 332 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.4 %

UNH stock opened at $597.64 on Friday. The stock’s 50 day moving average is $558.98 and its 200-day moving average is $515.15. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The firm has a market capitalization of $551.87 billion, a PE ratio of 36.53, a P/E/G ratio of 1.68 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the prior year, the company posted $6.14 earnings per share. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent research reports. HSBC increased their price objective on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Monday, August 19th. Argus boosted their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Wells Fargo & Company upped their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Finally, Royal Bank of Canada lifted their target price on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.